Abstract |
Cytidine metabolism in the yeast Saccharomyces cerevisiae was analyzed by genetic and biochemical approaches. Disruption of a unique ORF (Genbank accession No. U 20865) bearing homology with eucaryotic or bacterial cytidine deaminases abolished cytidine deaminase activity and resulted in 5-fluorocytidine resistance. The gene encoding cytidine deaminase will be referred to as CDD1 (Genbank accession number AF080089). The ability to isolate mutants resistant to 5-fluorocytidine which mapped to five other loci demonstrated the existence of a complex cytidine metabolic network. Deciphering this network revealed several original features:(1) cytidine entry is mediated by the purine-cytosine transporter (Fcy2p),(2) cytidine is cleaved into cytosine by the uridine nucleosidase (Urh1p),(3) cytidine is phosphorylated into CMP by the uridine kinase (Urk1p),(4) a block in cytosine deaminase (Fcy1p), but not in cytidine deaminase (Cdd1p), constitutes a limiting step in cytidine utilisation as a UMP precursor.
|
Authors | J E Kurtz, F Exinger, P Erbs, R Jund |
Journal | Current genetics
(Curr Genet)
Vol. 36
Issue 3
Pg. 130-6
(Sep 1999)
ISSN: 0172-8083 [Print] United States |
PMID | 10501935
(Publication Type: Journal Article)
|
Chemical References |
- Pyrimidines
- Deoxycytidine
- Cytidine
- Uridine Kinase
- Cytidine Deaminase
- 5-fluorocytidine
- Uridine
|
Topics |
- Amino Acid Sequence
- Chromatography
- Cytidine
(analogs & derivatives, genetics, metabolism, pharmacology)
- Cytidine Deaminase
(genetics, metabolism)
- Deoxycytidine
(metabolism)
- Drug Resistance
- Models, Biological
- Molecular Sequence Data
- Phenotype
- Phosphorylation
- Point Mutation
- Pyrimidines
(metabolism)
- Saccharomyces cerevisiae
(drug effects, genetics)
- Sequence Analysis, DNA
- Substrate Specificity
- Uridine
(metabolism)
- Uridine Kinase
(metabolism)
|